Maxime De Laere

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 15, 2024
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study.

Jolien Van den Bossche, Maxime De Laere, Koen Deschepper

|Jun 20, 2017
Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro.

Maxime De Laere, Carmelita Sousa, Megha Meena

Pageof 1

Frequent Collaborators

1 joint publications

Megha Meena

1 joint publications

Nathalie Cools